The answer is "yes", but the question is in what way? an article from Che et al. (2024) examines the use of real-world data (RWD) in ETS evaluations from ...
That's the title of a great review. Article by Salah Ghabri, Dalia Dawoud and Michael Drummond. This article notes that guidance on incorporating adverse ...
Why is it so difficult to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a ...
Diseases not only affect patients, but often also affect caregivers and family members. However, most economic analyzes ...
A recent article by Ben et al. (2023) provides an R tutorial for implementing economic evaluations (often ...